Politiparty
Politiparty
LeaderboardCongressBills

118th Congress Health

H.R. 3884: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Passed HouseSep 23, 2024

  1. Introduced (completed)Jun 7, 2023
  2. Passed House (completed)Sep 23, 2024
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Reported to House, Aug 25, 2023

This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

3

Bipartisan support.

Who scored on this bill

68 points earned
  1. 1Michael Burgess R-TX SponsorDrew cross-party cosponsors, introduced, reported, passed House4 events+56
  2. 2Earl Carter R-GACosponsored; cosponsored bill passed2 events+4
  3. 2Danny Davis D-ILCosponsored; cosponsored bill passed2 events+4
  4. 2Barbara Lee D-CACosponsored; cosponsored bill passed2 events+4
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Michael Burgess

History

  1. Sep 23, 2024Passed the House by voice vote.
  2. Jun 7, 2023Introduced in the House by Michael Burgess.
Show the full action history (16 actions)
  1. Sep 24, 2024Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  2. Sep 23, 2024Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
  3. Sep 23, 2024Considered under suspension of the rules. (consideration: CR H5578-5580)
  4. Sep 23, 2024DEBATE - The House proceeded with forty minutes of debate on H.R. 3884.
  5. Sep 23, 2024Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
  6. Sep 23, 2024On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
  7. Sep 23, 2024Motion to reconsider laid on the table Agreed to without objection.
  8. Aug 25, 2023Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
  9. Aug 25, 2023Placed on the Union Calendar, Calendar No. 132.
  10. Jul 19, 2023Committee Consideration and Mark-up Session Held.
  11. Jul 19, 2023Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
  12. Jul 13, 2023Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.
  13. Jul 13, 2023Subcommittee Consideration and Mark-up Session Held
  14. Jun 9, 2023Referred to the Subcommittee on Health.
  15. Jun 7, 2023Introduced in House
  16. Jun 7, 2023Referred to the House Committee on Energy and Commerce.